ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,184Medicare Part D Prescriptions Filled, Including Refills

Rank: 17 out of 212

$483K Total Retail Price of All Prescriptions

Rank: 24 out of 212

473 Patients Receiving at Least One Drug in Part D
94%Patients 65 Years and Older
76% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Hawaii
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

12% of this provider’s 473 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

2% of this provider’s 7,815 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$59 was the average price of a prescription from this provider, compared to $66 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Hawaii
ALENDRONATE SODIUM 838 823 1 16
SIMVASTATIN 599 571 2 1
AMLODIPINE BESYLATE 400 380 3 3
LOSARTAN-HYDROCHLOROTHIAZIDE 312 276 4 20
MELOXICAM 298 293 5 83
OMEPRAZOLE 216 207 6 9
METFORMIN HCL 213 199 7 5
LOSARTAN POTASSIUM 196 186 8 4
CLOBETASOL PROPIONATE 181 172 9 123
LISINOPRIL 162 151 10 2
LEVOTHYROXINE SODIUM 146 141 11 7
LIDODERM 143 143 12 108
GLIPIZIDE ER 132 132 13 55
RANITIDINE HCL 115 111 14 29
AZITHROMYCIN 114 107 15 40
ACTOS 101 101 16 68
ATORVASTATIN CALCIUM 95 90 17 6
TRAMADOL HCL 93 75 18 50
LOVASTATIN 91 91 19 12
TAMSULOSIN HCL 91 91 19 21
CIPROFLOXACIN HCL 89 86 21 80
ACETAMINOPHEN-CODEINE 88 85 S3 22 96
PANCRELIPASE 5,000 87 86 10 23 160
EVISTA 82 78 24 49
GABAPENTIN 78 75 25 22
FINASTERIDE 74 73 26 59
DIOVAN HCT 72 72 27 89
ACTONEL 71 71 28 73
DONEPEZIL HCL 71 71 28 25
MECLIZINE HCL 71 71 28 111
GLIPIZIDE-METFORMIN 69 56 31 176
FUROSEMIDE 68 67 32 11
NIFEDIAC CC 62 62 33 76
CELEBREX 60 59 34 42
ZOLPIDEM TARTRATE 59 48 35 26
PIOGLITAZONE HCL 55 55 R 36 117
HYDROCODONE-ACETAMINOPHEN 53 33 S3 37 10
CRESTOR 52 52 38 51
VOLTAREN 52 51 38 209
ZENPEP 52 48 38 209
DIOVAN 50 50 41 32
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 7, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.